• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者药物诱导病理性赌博的纹状体外多巴胺能异常:[11C]FLB-457 和 PET 研究。

Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

机构信息

Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Toronto, Ontario, Canada.

出版信息

Neurobiol Dis. 2012 Dec;48(3):519-25. doi: 10.1016/j.nbd.2012.06.021. Epub 2012 Jul 3.

DOI:10.1016/j.nbd.2012.06.021
PMID:22766031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3465363/
Abstract

Impulse control disorders such as pathological gambling (PG) are a serious and common adverse effect of dopamine (DA) replacement medication in Parkinson's disease (PD). Patients with PG have increased impulsivity and abnormalities in striatal DA, in common with behavioural and substance addictions in the non-PD population. To date, no studies have investigated the role of extrastriatal dopaminergic abnormalities in PD patients with PG. We used the PET radiotracer, [11C] FLB-457, with high-affinity for extrastriatal DA D2/3 receptors. 14 PD patients on DA agonists were imaged while they performed a gambling task involving real monetary reward and a control task. Trait impulsivity was measured with the Barratt Impulsivity Scale (BIS). Seven of the patients had a history of PG that developed subsequent to DA agonist medication. Change in [11C] FLB-457 binding potential (BP) during gambling was reduced in PD with PG patients in the midbrain, where D2/D3 receptors are dominated by autoreceptors. The degree of change in [11C] FLB-457 binding in this region correlated with impulsivity. In the cortex, [11C] FLB-457 BP was significantly greater in the anterior cingulate cortex (ACC) in PD patients with PG during the control task, and binding in this region was also correlated with impulsivity. Our findings provide the first evidence that PD patients with PG have dysfunctional activation of DA autoreceptors in the midbrain and low DA tone in the ACC. Thus, altered striatal and cortical DA homeostasis may incur vulnerability for the development of PG in PD, linked with the impulsive personality trait.

摘要

冲动控制障碍,如病理性赌博(PG),是帕金森病(PD)患者多巴胺(DA)替代药物的一种严重且常见的不良反应。PG 患者的冲动性增加和纹状体 DA 异常与非 PD 人群中的行为和物质成瘾相同。迄今为止,尚无研究调查 PD 伴 PG 患者的纹状体外多巴胺能异常的作用。我们使用具有高亲和力的 [11C] FLB-457 作为 PET 示踪剂,用于检测纹状体外 DA D2/3 受体。14 名正在服用 DA 激动剂的 PD 患者接受了 [11C] FLB-457 正电子发射断层扫描(PET),同时进行了涉及真实货币奖励的赌博任务和对照任务。特质冲动性通过巴雷特冲动量表(BIS)进行测量。其中 7 名患者在 DA 激动剂治疗后出现 PG 病史。在中脑,DA2/3 受体主要由自身受体支配,PG 伴 PD 患者在赌博过程中 [11C] FLB-457 结合潜能(BP)的变化减少。该区域 [11C] FLB-457 结合的变化程度与冲动性相关。在大脑皮层,PG 伴 PD 患者在对照任务期间,ACC 中的 [11C] FLB-457 BP 在前扣带回皮层(ACC)显著升高,该区域的结合也与冲动性相关。我们的发现首次提供了证据,表明 PD 伴 PG 患者的中脑 DA 自身受体功能障碍和 ACC 中的 DA 张力降低。因此,纹状体和皮质 DA 稳态的改变可能会导致 PD 中 PG 的易感性增加,这与冲动性人格特质有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa7/3465363/c1c759f5886f/nihms2373f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa7/3465363/0895ce6296da/nihms2373f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa7/3465363/1f9fff343011/nihms2373f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa7/3465363/c1c759f5886f/nihms2373f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa7/3465363/0895ce6296da/nihms2373f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa7/3465363/1f9fff343011/nihms2373f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa7/3465363/c1c759f5886f/nihms2373f3.jpg

相似文献

1
Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.帕金森病患者药物诱导病理性赌博的纹状体外多巴胺能异常:[11C]FLB-457 和 PET 研究。
Neurobiol Dis. 2012 Dec;48(3):519-25. doi: 10.1016/j.nbd.2012.06.021. Epub 2012 Jul 3.
2
Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.安非他明诱导的人类皮质多巴胺释放的正电子发射断层扫描成像:高亲和力多巴胺 D2/3 放射性示踪剂[11C]FLB 457 和[11C]法螺必利的比较评估
Synapse. 2009 Jun;63(6):447-61. doi: 10.1002/syn.20628.
3
Nigrostriatal and Mesolimbic D Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven Behaviors.帕金森病患者强迫性奖励驱动行为的黑质纹状体和中脑边缘 D 受体表达。
J Neurosci. 2018 Mar 28;38(13):3230-3239. doi: 10.1523/JNEUROSCI.3082-17.2018. Epub 2018 Feb 26.
4
Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease.早期和晚期帕金森病中的纹状体以外多巴胺D2和D3受体
Neurology. 2000 Apr 11;54(7):1482-7. doi: 10.1212/wnl.54.7.1482.
5
Dopaminergic function and intertemporal choice.多巴胺能功能与跨期选择。
Transl Psychiatry. 2015 Jan 6;5(1):e491. doi: 10.1038/tp.2014.133.
6
Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease.帕金森病前额叶多巴胺能受体异常与执行功能。
Hum Brain Mapp. 2013 Jul;34(7):1591-604. doi: 10.1002/hbm.22006. Epub 2012 Feb 14.
7
The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.病理性赌博中 D2/3 多巴胺受体:使用[11C]-(+)-丙基-六氢-萘并恶嗪和[11C]raclopride 的正电子发射断层扫描研究。
Addiction. 2013 May;108(5):953-63. doi: 10.1111/add.12066. Epub 2013 Jan 3.
8
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.帕金森病合并病理性赌博患者纹状体多巴胺释放增加:一项[11C]雷氯必利PET研究。
Brain. 2009 May;132(Pt 5):1376-85. doi: 10.1093/brain/awp054. Epub 2009 Apr 3.
9
The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.右旋苯丙胺对纹状体外多巴胺D2/D3受体的影响:一项在健康受试者中使用[11C]FLB 457进行的随机、双盲、安慰剂对照PET研究。
Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):475-83. doi: 10.1007/s00259-008-0969-9. Epub 2008 Nov 5.
10
[Pathological gambling and Parkinson disease].[病理性赌博与帕金森病]
Brain Nerve. 2008 Sep;60(9):1039-46.

引用本文的文献

1
Neural network localization in Parkinson's disease with impulse control disorders.帕金森病伴冲动控制障碍的神经网络定位
Front Aging Neurosci. 2025 Mar 28;17:1549589. doi: 10.3389/fnagi.2025.1549589. eCollection 2025.
2
Impulse control and related behavioral disorders in Parkinson's disease. Risk factors, diagnosis, and management. Is there a possible role for non-invasive brain stimulation?帕金森病中的冲动控制及相关行为障碍。危险因素、诊断与管理。非侵入性脑刺激是否可能发挥作用?
Neurol Sci. 2025 Apr 7. doi: 10.1007/s10072-025-08151-5.
3
Neuroimaging Biomarkers in Parkinson's Disease.

本文引用的文献

1
Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity.病理性赌博与物质使用障碍的异同:聚焦冲动性和强迫性。
Psychopharmacology (Berl). 2012 Jan;219(2):469-90. doi: 10.1007/s00213-011-2550-7. Epub 2011 Nov 5.
2
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications.前额叶皮层在成瘾中的功能障碍:神经影像学发现及临床意义。
Nat Rev Neurosci. 2011 Oct 20;12(11):652-69. doi: 10.1038/nrn3119.
3
Addiction circuitry in the human brain.
帕金森病的神经影像学标志物。
Adv Neurobiol. 2024;40:617-663. doi: 10.1007/978-3-031-69491-2_21.
4
Inhibition of Indirect Pathway Activity Causes Abnormal Decision-Making In a Mouse Model of Impulse Control Disorder in Parkinson's Disease.抑制间接通路活动会导致帕金森病冲动控制障碍小鼠模型出现异常决策。
bioRxiv. 2024 Nov 1:2024.02.19.581062. doi: 10.1101/2024.02.19.581062.
5
Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management.帕金森病相关冲动控制障碍:风险因素、发病机制及药物治疗概述。
CNS Drugs. 2024 Jun;38(6):443-457. doi: 10.1007/s40263-024-01087-y. Epub 2024 Apr 13.
6
Prefrontal Dopamine in Flexible Adaptation to Environmental Changes: A Game for Two Players.前额叶多巴胺在灵活适应环境变化中的作用:一场双人游戏
Biomedicines. 2023 Nov 30;11(12):3189. doi: 10.3390/biomedicines11123189.
7
Impulsivity Traits in Parkinson's Disease: A Systematic Review and Meta-Analysis.帕金森病中的冲动特质:系统评价与荟萃分析
Mov Disord Clin Pract. 2023 Jul 26;10(10):1448-1458. doi: 10.1002/mdc3.13839. eCollection 2023 Oct.
8
Accentuated Paralimbic and Reduced Mesolimbic D-Impulsivity Associations in Parkinson's Disease.帕金森病患者边缘旁回和中边缘系统冲动控制的增强和减弱。
J Neurosci. 2023 Dec 13;43(50):8733-8743. doi: 10.1523/JNEUROSCI.1037-23.2023.
9
Impulse control disorder in Parkinson's disease is associated with abnormal frontal value signalling.帕金森病中的冲动控制障碍与额叶价值信号异常有关。
Brain. 2023 Sep 1;146(9):3676-3689. doi: 10.1093/brain/awad162.
10
Translational molecular imaging and drug development in Parkinson's disease.帕金森病的转化分子影像学与药物研发。
Mol Neurodegener. 2023 Feb 10;18(1):11. doi: 10.1186/s13024-023-00600-z.
人类大脑中的成瘾回路。
Annu Rev Pharmacol Toxicol. 2012;52:321-36. doi: 10.1146/annurev-pharmtox-010611-134625. Epub 2011 Sep 27.
4
Parkinson disease: impulsive choice-Parkinson disease and dopaminergic therapy.帕金森病:冲动选择——帕金森病与多巴胺能治疗
Nat Rev Neurol. 2011 Sep 13;7(10):541-2. doi: 10.1038/nrneurol.2011.139.
5
Impulse control disorders in Parkinson's disease: recent advances.帕金森病中的冲动控制障碍:最新进展。
Curr Opin Neurol. 2011 Aug;24(4):324-30. doi: 10.1097/WCO.0b013e3283489687.
6
Dopamine agonists and risk: impulse control disorders in Parkinson's disease.多巴胺激动剂与风险:帕金森病中的冲动控制障碍。
Brain. 2011 May;134(Pt 5):1438-46. doi: 10.1093/brain/awr080.
7
Impulse control disorders in Parkinson disease: a multicenter case--control study.帕金森病患者的冲动控制障碍:一项多中心病例对照研究。
Ann Neurol. 2011 Jun;69(6):986-96. doi: 10.1002/ana.22356. Epub 2011 Mar 17.
8
Addiction: beyond dopamine reward circuitry.成瘾:超越多巴胺奖赏回路。
Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15037-42. doi: 10.1073/pnas.1010654108. Epub 2011 Mar 14.
9
Regulation of dopaminergic neuron firing by heterogeneous dopamine autoreceptors in the substantia nigra pars compacta.黑质致密部多巴胺自受体的异质性调节多巴胺能神经元的放电。
J Neurochem. 2011 Mar;116(6):966-74. doi: 10.1111/j.1471-4159.2010.07107.x. Epub 2011 Feb 9.
10
Systematic review of levodopa dose equivalency reporting in Parkinson's disease.帕金森病左旋多巴剂量等效报告的系统评价。
Mov Disord. 2010 Nov 15;25(15):2649-53. doi: 10.1002/mds.23429.